Teresa Huguet-Termes had to overcome many obstacles in European as well as in Spanish medicine in the sixteenth century.4
As Guenter Risses has commented, at a time when the Spanish crown dominated a large part of Europe and was building up a world empire, most of the inhabitants of sixteenth-century Spain lived in rural areas. Diseases such as plague, leprosy, typhus and the great pox extended with demographic and economic consequences even through the upper and middle classes of society. Certain specific points are worth noting. There was a shortage of university-trained physicians and Latinate surgeons (those with academic training), who practised in cities and at the royal court and who were employed by municipalities and hospitals. These elite physicians treated members of the aristocracy and prominent clergymen. Other kinds of practitioners included non-Latinate surgeons often employed in the armies and navies, empirics who treated specific problems requiring practical skills, and also practitioners belonging to the Jewish and Morisco minorities marginalized into an illegal status by the Catholic majority.6 The Spanish crown created in 1477 the "Protomedicato": a body charged with the responsibility of regulating medical practitioners.7 Different trends within Galenic theory constituted the prevailing medical system of thought.8 There were as well a wide variety of European and Eastern drugs in circulation in huge quantities. All of this may have militated against the introduction of new medical theories and a new armamentarium.
The idea that only a few American drugs were used in Europe and therefore had little impact has been perpetuated without much questioning or investigation. Joseph Ewan stated that the bearing which Columbian discoveries had on the development of botanical concepts in sixteenth-century Europe was slight, and that our understanding of plants, their forms and functions was the result first of stumbling confusion, then of slow awakening during the centuries.9 There has, until recently, 'For useful Dynamis, 1996, 16. 8For an excellent survey, see Jose Maria L6pez Piniero, 'Tradici6n y renovaci6n en la medicina espaniola del Renacimiento', in Jose Maria L6pez Pifiero (ed.), Viejo y nuevo New World Materia Medica in Spanish Renaissance Medicine been little research into the ways in which American materia medica was distributed and assimilated into European medical practice. Jonathan Sauer, another scholar interested in the subject, after examining textual evidence, wrote that "many of the species were soon introduced, but acceptance there was another story".'" Charles Talbot went even further and even contradicted himself to some extent:
All in all, while the number of drugs discovered in the New World was considerable and while their importation into Europe enriched numerous merchants and druggists, their influence on European medicine was negligible. The reasons for this were mainly ignorance, conservatism and a lack of confidence on the part of the medical profession, and the exaggerated claims, sometimes wholly unfounded made by unscientific travellers and unscrupulous practitioners." It is well known that the Spaniards rejected the magico-religious context in which the plants were used by the indigenous people of America, and that they also insisted on incorporating these plants into the Galenic humoral system. Therefore, the argument goes, anything which did not fit or was not considered effective within the context of a set of empirico-rational judgements about bodily processes common to both "worlds" was rejected.'2 Then too, important works on American plants such as the Codices of de la Cruz-Badiano and Bernardino de Sahaguin, and Hernandez's massive reports were, we are told, hidden in libraries for a long time and no one used their information. Both these circumstances prevented the introduction of new drugs and brought "little of truly lasting therapeutic value from the New World ... save for the four drugs [chinchona, ipecacuana, cocaine and curare] that achieved prominence only 150 years or more after Columbus first visited the Americas".13
New research has thrown doubt on this view, which I believe was too influenced by the expectation of finding out-in the process of assimilation of a new armamentarium-events which seemed significant from the perspective of modern medicine.'4 This paper, although sometimes in a tentative way, aims to reconsider various sources, and will explore some aspects of the assimilation of American drugs into sixteenth-century medical theory, and look at their practical impact between 1492 and 1600. First, it will look at information relating to American drugs contained in printed texts; then it will consider the distribution and use of these medicinal°J onathan D Sauer, 'Changing perception and exploitation of the New World plants in Europe, 1492 -1800 Although the number of American plants Laguna included was small,33 his references were explicit enough to show that American drugs were taken very seriously when no similar drugs were available for common illnesses or when they were associated with the healing of new and dangerous diseases. He included among new plants only those that were absolutely necessary to cover therapeutic needs. He did not discard American plants from a theoretical point of view, he simply thought that not all of them were necessary. By contrast, those he did list, he fitted into the Galenic system as substitutes for plants described by Dioscorides History, 1988, 30 (1): 27-32, p. 29.
32Andres Laguna, Pedacio Dioscorides Anazarbeo, acerca de la materia medicinal, y de los venenos mortiferos, traducido de la lengua griega en la vulgar castellana, e illustrado con claras y substanciales annotationes y con las figuras de innumeras plantas exquisitas y raras, Salamanca, Mathias Gast, 1566, reprinted in Madrid, Instituto de Espafia, 1968. 33Jose Luis Fresquet Febrer, 'Terapeutica y materia medica americana en la obra de Andres Laguna (1555) ', Asclepio, p. 82, and Enrique Alvarez Lopez, 'Las plantas de America en la botanica europea del siglo XVI', Revista de Indias, 1945, 19-22: 221-88, p. 264. An example of this is the balsam that Dioscorides had described but which could not be found nor identified. Laguna did not hesitate to include an explicit reference to the New Spain balsam in his commentary, giving it the virtue (gracia) of being a more useful substitute than the "real one", probably meaning an Eastern substitute. He stated that it was wonderful for many ailments, referring to it as a sovereign remedy.34
Another drug he mentioned was estoraque from New Spain, which he identified as the unique substitute of the Storax Styracinus mentioned by Dioscorides.35 Perhaps the reason for the prominent place which Laguna gave to new balsam and estoraque was the unavailability of other substitutes. This seems not to have been the case with frankincense, terebinth, gum and sandalwood (surprisingly the Portuguese provided sandalwood in large quantities36) for which substitutes would have been easy to find in the rare event of the "real plants" not being available.
So, for example, we might argue that Laguna did not make any mention of purgative nuts, canafistula, fig tree of hell oil (higuera del infiernolquauhayohuachtli),37 all purgatives found in the New World, because there were plenty of other well-known purgatives such as Ricinus and rhubarb in Europe.
The way in which Laguna wrote about guaiacum and sarsaparilla shows that they had already been assimilated into the Galenic medical system as "new medicines" for "new diseases", mainly the great pox.38 The Christian belief that God supplied the remedies for diseases may well have influenced their quick assimilation, at both theoretical and practical levels. Laguna saw guaiacum, in particular, as a remedy that should not be criticized, and from the very beginning elite physicians felt confident about using it. Commenting on sarsaparilla and China root (raiz de China),39 Laguna wrote, "It is true that at first, before these plants were understood, as the world loves novelties, they were greatly sought after, especially that called China".40 It seems that Laguna believed that a knowledge of the action of these plants was necessary before they could be used.
Other Teresa Huguet-Termes example, Mechoacan root5" and tacamahaca (tacamahacaltecomahaca).52 But his book was translated into Latin in 1574 by Clusius53 and also widely read by high ranking physicians,54 so it does need to be seriously considered as an important step in the scholarly assimilation of American drugs.
The success of Monardes' work all over Europe raised people's expectations of the medical and scientific value of American plants and this led Philip II in 1570 to send Francisco Hernandez (1515-87) to America to study the flora and the fauna. Hema'ndez moved in the medical circles of the Spanish court and was well trained for such a mission. Philip II saw an opportunity to exploit the natural resources of his empire.55
The results of Hema'ndez's expedition included living plants, planted in barrels and pots, "sixty-eight sacks of seeds and roots", paintings of plants and animals on pine panels, and thirty-eight volumes containing paintings and texts.56 Some historians have asserted that Hema'ndez's manuscripts had little impact on scholarly medicine in the sixteenth century,57 but I am more inclined to agree with Lopez Pifiero and Pardo Toma's who have recently put forward a different theory.58 According to them, although a resume of Hernandez's works made by Nardo Antonio Recchi, at the request ofPhilip II, was not distributed until 1651,5 information from the manuscripts and reports of the expedition circulated widely, and we know that many important physicians such as Francisco Valles, Ulisse Aldrovandi, Joachim Camerarius and many others had a look at them.60 In fact, in 1580, Philip II appointed Recchi court physician with the primary responsibility of studying the materials of Hema'ndez and of making a selection of the plants most valuable from a healing point of view. Among the 400 selected plants we find all the American drugs that were relevant in the expansion of the therapeutic "arsenal" in European medicine from the late Renaissance to the Baroque period.6' Further, Francisco Ximenez, the Dominican doctor, published in Mexico a translation into Spanish of Recchi's selection in 1615.62 We must consider seriously that Hema'ndez's materials had circulated in manuscript 51 Monardes, op. The Impact of American Drugs on Medical Practice I have been discussing the scholarly view of these drugs. I would now like to look at how they were assimilated at a practical and domestic level.
Monardes described Seville as a great pharmaceutical market, listing several of the imported drugs. For instance, regarding liquid amber, he stated, "There is brought muche quantitie of liquid amber to Spaine ... to perfume in thinges of sweete smelles, wasting it in place of Storacke"8' and "There is knowen of this plaister verie greate experience, in this Citie, for the good effect that it doeth".82 It seems that trade continued until 1574 when Monardes again wrote, "There is brought muche quantitie of liquid amber to Spaine, in so muche that they doe bringe many Pipes, and Barelles full thereof to sell for Merchaundise." 83 Monardes also referred to the use of balsam since the discovery of New Spain and to its arriving in large amounts, as well as its common use in Seville.84 He may have exaggerated the last point. Pierre Chaunu has shown that between 1568 and 1619 at least 209 tons of canafistula (about two and a half million doses), 670 tons of sarsaparilla (about seven and a half million doses), and 930 tons of guaiacum (two and a half million doses) were brought into the port of Seville.85 One would therefore expect the city's apothecaries to have stocked many American drugs. But, extremely surprisingly, given that this city was the port of entry for all these therapeutic novelties, in the inventories of apothecaries in Seville from 1551 to 1609 (1551, 1570, 1573, 1609) 86 there is very little mention of American drugs. Those that are listed are canafistula (20 lbs, enough for preparing eighty doses) and Mechoacan root, which appear in two inventories of 1570; 7 sarsaparilla (3 lbs, enough for twelve Frampton, op. physicians,' these drugs do not appear in the inventories of hospital apothecaries, and physicians continued throughout the century to treat patients with mercurials.9' American drugs are also seldom listed in the official pharmacopoeias that appeared in Spain in the sixteenth century and which established the rules for stocking and preparing remedies. Taking the example of the later editions of the pharmacopoeias of Barcelona (1587) New World Materia Medica in Spanish Renaissance Medicine report that "such great quantities of canafistula are now being brought in laden vessels from those lands that there is sufficient to supply not only Spain, but all Europe and even the Levant","109 should make us think more about this first possibility.
Was a great demand for new healing tools the reason why apothecaries' stocks were quickly used up, and does this also explain the absence of American drugs in Sevillian pharmacies? This is very unlikely in my view, because, even assuming a great demand, not all the apothecaries could have coped with it. We must bear in mind that those apothecaries who wanted to trade in American drugs became "associated" like the rest of the traders. Within the system of Atlantic commerce between Spain and America, associations were based on private companies. They were directed by a limited group of contractors and individuals, under government rules. These associations consisted of physicians, surgeons, apothecaries and merchants."' Also included were ships' masters, officers of the Casa de Contratacion and notaries of the Inquisition."' All these people, as well as the apothecaries, could sell these drugs. The trade in American drugs seems to have been chiefly in the hands of certain rich apothecaries such as Bernardino Historians have argued that part of the evidence that the discovery of new medicinal plants had little impact on actual practice lies in the fact that the pharmacies were slow to stock them.'2' I suggest that the absence of American drugs from Spanish and even Sevillian pharmacies must not be taken as an argument for stating categorically that American drugs did not influence medical practice. The amount imported and the existing evidence do not give much credibility to either of the previous hypotheses. This led me to consider the possibility that the new drugs were distributed outside the environment of the learned elite, in "an underground way". Different kinds of accounts give us an idea of how this may have happened.
We know from the writings of the early chroniclers that the new drugs soon became widely known. The fact that Spanish drugs deteriorated on the long voyage out to America led the early settlers to use indigenous plants. Pedro Arias de Benavides, a surgeon who practised in America and wrote a book after his return, explained, "The simples were damaged by the long period of storage in Spain, followed by a long sea voyage and then the time it took for them to be sold to apothecaries in the Indies. The merchants would hold on to them until there was a demand, and then the shops too kept the simples a long time; inevitably they were ruined." ''22 So it is clear that Spaniards in New Spain knew and used these drugs themselves. This makes very possible similar self-medication when they returned, and also the transfer of this new knowledge to others when they were back home. Fernandez de Oviedo also referred to this self-experimentation as a way of assimilating knowledge. He mentions Juan de la Vega who experimented with purgative nuts in Spain in 1513, like many other people, without the supervision of a doctor, claiming that Spanish doctors did not know about the nuts or understand how to use them. De la Vega tested the drug on one of his nephews, who died as a consequence. Oviedo commented briefly, "From this he learnt".'26
Another purgative was the fig tree of hell oil, which, according to Monardes, had been shown to have "greate vertues" and was used by many people in the Indies as well as in Spain and, similarly, he noted that tacamahaca had also been proved effective by experimentation. '27 Information was spread by word of mouth,'28 and by gifts and exchange. Writing about guaiacum, Monardes said that news of it was communicated by people who came from America to Seville. Afterwards it spread all over Spain, and later to the rest of the world.'29 Fernandez de Oviedo remarked that "Just as supplies were brought for His Majesty, so too they arrived for merchants and other individuals". 130
Apart from the monopoly trade system, there is evidence of the existence of widespread private exchange between individuals from America to Spain although it is difficult to evaluate systematically. This private exchange may have been promoted because the trade in medicinal products was not seen as a way of making a big fortune by comparison with the trade in other products, such as sugar, for which there was more demand and profit. One documented example of a private exchange is Benavides' report that when he returned to Toro, his home town in Spain, he sent Bernardino del Castillo some presents because del Castillo had never asked for payment for plants of his own, including Mechoacan root, that he had given Benavides for medicinal use.'3' Such exchanges may have well influenced a trade in cheaper drugs-outside the merchants' control-between individuals from America and people in Spain. Travellers from America also often wanted to be healed with the products they had brought with them.'32 Information in letters sent 125Ibid., vol. 1, p. 379.
Trevinlo, Universidad Nacional Aut6noma de 126 Ibid., vol. 1, p. 369. Mexico, 1984-1990, pp. 175-201, p Monardes mentions tacamahaca as being very popular for all kinds of pain, particularly among women, and refers to their curiosity in trying to mix it with other remedies such as amber or musk.'" Arias de Benavides, too, said that the women of Castille used this plant, and that it was imported by those who had travelled to the Indies.'35 This seems to indicate that it was used by lay people and not just the medical profession. Garcia Ballester's studies of Morisco physicians also show that Morisco medical practitioners and their women knew about tacamahaca and used it.'36 Since they belonged to a low, unpowerful and highly marginalized social group, this is another indication of the wide dispersal of drugs from the New World through all social levels. The Morisco practitioners based their therapy on two main vernacular books. One of them, already mentioned, was Fragoso's Discursos de las cosas aromaticas (1572), in which knowledge and uses of many American drugs were explained. The other was Laguna's edition of Dioscorides's Materia medica. Another American drug which the poor used was balsam. It was very expensive at first, but Monardes stated that later, "After that they brought so muche and suche great quantity, that it is nowe of small valewe". This may have happened with some of the other expensive American drugs adopted as "unique" substitutes. The increased quantities imported and the fall of prices would have encouraged their use among the poorest social groupings, and this may have discouraged medical men from using them. Certainly, because balsam was very popular, Monardes wrote, "the use thereof is a common Medicine in all surgery of poore folkes: Seeyng that with one medicine all effectes is doen".'37
But there is no reference to balsam in the case histories of Luis Mercado for the treatment of injuries and skin ailments, nor in the surgical treatises of Latinate surgeons, such as Juan Calvo and Fragoso, who were closer to the medical elite. Wealthy patients may have been reluctant to be treated with this popular and cheap remedy, and preferred, for instance, a ceite de Aparicio, a compound remedy made of ingredients found locally or imported from the East, much used for wound therapy.'38 When Fragoso, in 1572, reported "the much higher quality of the aromatic plants of the Levant compared with those of our New World Materia Medica in Spanish Renaissance Medicine existence of two parallel markets, the oriental one, most suitable for the therapy practised by learned physicians and directed at the rich, and the American one, much cheaper because of its being a "national" product. It seems that public health officers also were aware of the economic benefits of using certain American products. Towards the end of the century, ships of the navy were provided with canafistula,140 as was the apothecary of the Hospital de la Sta Creu of Barcelona in 1585.141 Although there existed an Indian species, the American species was much larger, and the cost-benefit relation seemed to be appreciated by public health officers.
On the other hand, the attitude of the royal court to the consumption of American drugs was important. During most of the second half of the sixteenth century the apothecaries who supplied the royal family and their servants did not depend directly upon the palace. The king used the services of wealthy apothecaries who supplied the court with the drugs prescribed by court physicians. During the second half of the sixteenth century, two groups of apothecaries held this position, the Arigon and Arenzano families,'42 both of whom supplied the king with American drugs such as guaiacum and canafistula as early as 1545, 1546 and 1547. 14 
Conclusions
My researches so far have produced more questions than answers, although I suggest that the use of American drugs in sixteenth-century Spain has been underestimated. The information contained in archives, especially the Archivo de Indias, has not been studied systematically regarding the subject of this paper. Other areas might produce interesting results. For instance, I have not been able to investigate in depth the use of these drugs by general surgeons and navy physicians, and in hospitals. Much more work needs to be done on the trade in drugs between Spain and other countries, and on the whole question of the impact of American drugs on European medicine at all social levels, but particularly at a practical level among low social groupings. Another interesting aspect I have not been able to go into is the cultivation of American drugs in Spain and elsewhere. Nevertheless, I think I have demonstrated that the practical impact of American products was a fact and that the medical establishment did not react against them as has been '"Pilar Arrebola, Jose Luis Valverde, believed.'" Some drugs did enter Spain in large quantities and medical writers did make an effort to include some within the traditional Galenic medical schema of interpretation. But the big question still remains. Where did all the drugs imported into Spain then go?
Although focusing on a period about a hundred years later, the model of assimilation and dispersal that Saul Jarcho proposes for quina seems to have some parallels with the model I have drawn, especially for the "new drugs". It would be interesting to do further comparative work. Saul Jarcho, Quinine's predecessor: Francesco Torti and the early history of chinchona, Baltimore and London, Johns Hopkins University Press, 1993. 
